Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
NCT00539526
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class
Conditions
Open Angle Glaucoma
Ocular Hypertension
Interventions
DRUG:
Bimatoprost 0.03%
DRUG:
travoprost 0.004%
DRUG:
latanoprost 0.005% eye drops
Sponsor
Allergan